Effect of wnt aberrant methylation and epidermal growth factor receptor pathway mutation on responsiveness of non-small cell lung cancer to gefitinib and erlotinib.
J. Zhu
No relevant relationships to disclose
J. Wang
No relevant relationships to disclose
H. Bai
No relevant relationships to disclose
J. Zhao
No relevant relationships to disclose
Z. Wang
No relevant relationships to disclose
M. Zhuo
No relevant relationships to disclose
T. An
No relevant relationships to disclose
J. Duan
No relevant relationships to disclose
L. Yang
No relevant relationships to disclose
M. Wu
No relevant relationships to disclose
Q. Guo
No relevant relationships to disclose
X. Liu
No relevant relationships to disclose
S. Wang
No relevant relationships to disclose
Y. Wang
No relevant relationships to disclose